Early Access — free while we kick the tires
EdgarHawk

Shaker Sadasivam

Director

Director

Latest: Director buying · May 2026

2 filings analyzed · 2 companies · Latest 2026-05-07
Validated high-conviction buyer — this insider’s opportunistic purchases fall in a cohort whose buys have historically preceded above-benchmark moves. How we measure this ↗

Companies

Company Buys Sells Direction
FTC Solar, Inc. FTCI 1 0 Net buying
COHERENT CORP. COHR 0 5 Net selling

Activity

May 2026
2026-05-07 FTC Solar, Inc. FTCI
high
Buy
27,025 shares
$99,992
Significance 6/10

Director Sadasivam buys 27K shares of FTCI at depressed valuations; stock down sharply over past quarter but rallying recently.

Director Shaker Sadasivam purchased a substantial stake representing roughly half his current holdings, deploying nearly $100K at a moment when the stock is trading well below its highs. This is his third documented buy in FTC Solar, adding to two prior purchases from 2023 whose outcomes remain too recent to evaluate. The company faces significant profitability headwinds—generating substantial losses on an annual basis—but the latest quarterly results surprisingly turned positive, hinting at a potential operational inflection. Sadasivam's willingness to increase his exposure during a period of financial distress and depressed valuations suggests conviction that the recent positive quarter may signal a genuine turnaround, rather than a one-time anomaly. The stock has recovered modestly over the past month despite the severe longer-term decline, creating a window where a director might view current prices as attractive entry points for conviction buyers.

June 2025
2025-06-05 COHERENT CORP. COHR
high
Sell
29,292 shares
$2,343,360
Significance 6/10

Director Sadasivam Shaker sold 29,292 shares of COHR at $80.00 on 2025-06-03, reducing holdings by 43.1%; stock now down 28.9% from 52-week high.

Director Sadasivam Shaker executed a substantial open-market sale of 29,292 shares worth $2,343,360.00, reducing his stake from 67,914 to 38,622 shares (a 43.1% reduction in holdings). The timing coincides with weakness in the stock—trading at $79.65, down 28.9% from the 52-week high of $112.02—though the stock has rallied 14.1% over the preceding 30 days and 19.7% over 90 days. Notably, the company faces significant headwinds: revenue declined 8.8% year-over-year, it was unprofitable over its most recent full fiscal year, and the stock carries an elevated valuation at P/E 128.47 despite negative full-year earnings. The sale represents a material reduction in director commitment at a time of operational and financial weakness.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access